Viatris Inc. (NASDAQ:VTRS) Barclays 27th Annual Global Healthcare Conference Call March 11, 2025 2:00 PM ET
Company Participants
Scott Smith – Chief Executive Officer
Doretta Mistras – Chief Financial Officer
Conference Call Participants
Balaji Prasad – Barclays
Balaji Prasad
Good afternoon, everyone. Thank you all for joining us at the Barclays Healthcare Conference, continuing our spec pharma session for the day. I’m delighted to have the CEO of Viatris, Scott Smith; and Doretta Mistras, the CFO of Viatris. Scott, I know you’re not scheduled to come here originally and really delighted that you could make it and we could have you here. So I appreciate that. And I would love to get you to get started with some opening remarks around recent Q4 results and outlook you provided, and then we could jump into some Q&A.
Scott Smith
Sure. So first of all, thank you very much for being flexible and getting us in here at this time slot. It’s – we’re very happy to be here. Thank you, everybody, for attending. And Doretta and I are going to run through some questions. And I think sort of the first thing is we had our earnings call a couple of weeks ago. We put earnings out. We had the – we talked about the effect of the plant called Indore on sales into the United States in revenues and EBITDA. And so we reset sort of the base a little bit for where we’re going in ‘25 based on that.
One of the things I get a lot of questions from, it’s been a very busy period of time from an investor perspective. And from my perspective, the questions they’re asking is, has anything changed? Talk about the base business? What about new product revenue? And from my perspective, really nothing has changed. We do have a little bit
Credit: Source link
